JP2000515866A5 - - Google Patents

Download PDF

Info

Publication number
JP2000515866A5
JP2000515866A5 JP1998508318A JP50831898A JP2000515866A5 JP 2000515866 A5 JP2000515866 A5 JP 2000515866A5 JP 1998508318 A JP1998508318 A JP 1998508318A JP 50831898 A JP50831898 A JP 50831898A JP 2000515866 A5 JP2000515866 A5 JP 2000515866A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998508318A
Other languages
English (en)
Japanese (ja)
Other versions
JP4033494B2 (ja
JP2000515866A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013244 external-priority patent/WO1998004569A1/en
Publication of JP2000515866A publication Critical patent/JP2000515866A/ja
Publication of JP2000515866A5 publication Critical patent/JP2000515866A5/ja
Application granted granted Critical
Publication of JP4033494B2 publication Critical patent/JP4033494B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50831898A 1996-07-26 1997-07-25 ヌクレオチドアナログ Expired - Lifetime JP4033494B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68683896A 1996-07-26 1996-07-26
US2270896P 1996-07-26 1996-07-26
US60/022,708 1996-07-26
US08/686,838 1996-07-26
PCT/US1997/013244 WO1998004569A1 (en) 1996-07-26 1997-07-25 Nucleotide analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007180398A Division JP2007297406A (ja) 1996-07-26 2007-07-09 ヌクレオチドアナログ

Publications (3)

Publication Number Publication Date
JP2000515866A JP2000515866A (ja) 2000-11-28
JP2000515866A5 true JP2000515866A5 (OSRAM) 2004-08-19
JP4033494B2 JP4033494B2 (ja) 2008-01-16

Family

ID=26696272

Family Applications (6)

Application Number Title Priority Date Filing Date
JP50831898A Expired - Lifetime JP4033494B2 (ja) 1996-07-26 1997-07-25 ヌクレオチドアナログ
JP2007180398A Withdrawn JP2007297406A (ja) 1996-07-26 2007-07-09 ヌクレオチドアナログ
JP2010233086A Withdrawn JP2011016847A (ja) 1996-07-26 2010-10-15 ヌクレオチドアナログ
JP2014083387A Withdrawn JP2014159450A (ja) 1996-07-26 2014-04-15 ヌクレオチドアナログ
JP2015091141A Withdrawn JP2015164934A (ja) 1996-07-26 2015-04-28 ヌクレオチドアナログ
JP2016212748A Withdrawn JP2017031212A (ja) 1996-07-26 2016-10-31 ヌクレオチドアナログ

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2007180398A Withdrawn JP2007297406A (ja) 1996-07-26 2007-07-09 ヌクレオチドアナログ
JP2010233086A Withdrawn JP2011016847A (ja) 1996-07-26 2010-10-15 ヌクレオチドアナログ
JP2014083387A Withdrawn JP2014159450A (ja) 1996-07-26 2014-04-15 ヌクレオチドアナログ
JP2015091141A Withdrawn JP2015164934A (ja) 1996-07-26 2015-04-28 ヌクレオチドアナログ
JP2016212748A Withdrawn JP2017031212A (ja) 1996-07-26 2016-10-31 ヌクレオチドアナログ

Country Status (4)

Country Link
JP (6) JP4033494B2 (OSRAM)
CA (1) CA2261619C (OSRAM)
TW (2) TW470748B (OSRAM)
WO (1) WO1998004569A1 (OSRAM)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2261619C (en) * 1996-07-26 2006-05-23 Gilead Sciences, Inc. Nucleotide analogs
SI1256585T1 (en) * 1997-07-25 2005-02-28 Gilead Sciences, Inc. Process for preparing 9-(2-(diethylphosphonomethoxy)ethyl)-adenine
EP1243590B1 (en) * 1997-07-25 2005-02-09 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
DE69829010T2 (de) * 1997-07-25 2006-04-13 Gilead Sciences, Inc., Foster City Nukleotid-Analog Zusamensetzung und Synthese Verfahren
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
AU2001282941C1 (en) * 2000-07-21 2016-12-22 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
EA008775B1 (ru) 2002-04-26 2007-08-31 Джилид Сайэнс, Инк. Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция
JP4996241B2 (ja) 2003-01-14 2012-08-08 ギリアード サイエンシーズ， インコーポレイテッド 組み合わせ抗ウイルス治療のための組成物および方法
CA2523083C (en) 2003-04-25 2014-07-08 Gilead Sciences, Inc. Antiviral phosphonate analogs
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
CN101410120A (zh) * 2003-04-25 2009-04-15 吉里德科学公司 抗炎的膦酸酯化合物
US7417055B2 (en) 2003-04-25 2008-08-26 Gilead Sciences, Inc. Kinase inhibitory phosphonate analogs
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
WO2004096285A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
SI1644389T1 (sl) 2003-06-16 2011-06-30 Acad Of Science Czech Republic Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
US7432273B2 (en) 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US7427624B2 (en) 2003-10-24 2008-09-23 Gilead Sciences, Inc. Purine nucleoside phosphorylase inhibitory phosphonate compounds
CA2543294A1 (en) 2003-10-24 2005-05-26 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds
CA2548951A1 (en) * 2003-12-22 2005-07-14 Gilead Sciences, Inc. Kinase inhibitor phosphonate conjugates
AU2004309418B2 (en) 2003-12-22 2012-01-19 Gilead Sciences, Inc. 4'-substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity
JP2008508291A (ja) 2004-07-27 2008-03-21 ギリアード サイエンシーズ， インコーポレイテッド 抗ｈｉｖ剤としてのヌクレオシドホスホネート結合体
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
JP5323476B2 (ja) * 2005-06-13 2013-10-23 博瑞生物医葯技▲術▼（▲蘇▼州）有限公司 ヌクレオチド類縁体プロドラッグおよびその製剤
EP2161023A3 (en) 2007-04-13 2010-12-29 Southern Research Institute Anti-angiogenic agents and methods of use.
CN101778855A (zh) * 2007-05-22 2010-07-14 阿尔迪默菲克斯技术有限责任公司 替诺福韦酯半富马酸共晶体
WO2009064174A1 (en) * 2007-11-14 2009-05-22 Ultimorphix Technologies B.V. Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
AU2008355336B2 (en) * 2008-04-25 2014-04-10 Cipla Limited Crystalline form of tenofovir disoproxil and a process for its preparation
EP2307435B1 (en) 2008-07-08 2012-06-13 Gilead Sciences, Inc. Salts of hiv inhibitor compounds
CN102093422B (zh) * 2009-12-10 2015-02-25 中国人民解放军军事医学科学院毒物药物研究所 无环核苷膦酸酯衍生物及其医药用途
NZ615939A (en) * 2011-05-10 2015-04-24 Aratana Therapeutics Nv Compounds for use in the treatment of feline retroviral infections
DK2744810T4 (da) 2011-08-16 2023-11-20 Gilead Sciences Inc Tenofovir-alafenamid-hemifumarat
CN103626802A (zh) * 2012-08-23 2014-03-12 重庆药友制药有限责任公司 一种制备替诺福韦的新方法
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
CA2889903C (en) 2012-10-29 2021-03-09 Manjinder Singh Phull Antiviral phosphonate analogues and process for preparation thereof
PT2860184T (pt) 2013-10-09 2018-11-20 Zentiva Ks Sal de di-hidrogenofosfato de tenofovir disoproxil
EP2860185A1 (en) 2013-10-09 2015-04-15 Zentiva, k.s. An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
TWI660965B (zh) * 2014-01-15 2019-06-01 美商基利科學股份有限公司 泰諾福韋之固體形式
EP3661937B1 (en) 2017-08-01 2021-07-28 Gilead Sciences, Inc. Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
CN107805202A (zh) * 2017-12-01 2018-03-16 内蒙古圣氏化学股份有限公司 一种氯甲基异丙基碳酸酯连续化反应装置及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84477A (en) * 1986-11-18 1995-12-08 Bristol Myers Squibb Co History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them
EP0481214B1 (en) * 1990-09-14 1998-06-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Prodrugs of phosphonates
GB9026164D0 (en) * 1990-12-01 1991-01-16 Beecham Group Plc Pharmaceuticals
CA2171743C (en) * 1993-09-17 2007-11-20 Norbert W. Bischofberger Nucleotide analogs
CA2261619C (en) * 1996-07-26 2006-05-23 Gilead Sciences, Inc. Nucleotide analogs

Similar Documents

Publication Publication Date Title
JP2002515780A5 (OSRAM)
JP2000502280A5 (OSRAM)
JP2000501771A5 (OSRAM)
JP2000501599A5 (OSRAM)
JP2000501018A5 (OSRAM)
JP2000500076A5 (OSRAM)
JP2000501324A5 (OSRAM)
JP2000500055A5 (OSRAM)
JP2000500026A5 (OSRAM)
JP2000502472A5 (OSRAM)
JP2000501338A5 (OSRAM)
JP2000501825A5 (OSRAM)
JP2000500874A5 (OSRAM)
JP2000502425A5 (OSRAM)
JP2000502485A5 (OSRAM)
JP2000502568A5 (OSRAM)
JP2000501774A5 (OSRAM)
JP2000500912A5 (OSRAM)
JP2000502570A5 (OSRAM)
JP2000501876A5 (OSRAM)
JP2000501744A5 (OSRAM)
JP2000501229A5 (OSRAM)
JP2000502316A5 (OSRAM)
JP2000500857A5 (OSRAM)
JP2000502714A5 (OSRAM)